Patent classifications
A23L33/14
YEAST CELL WALL DERIVED FLAVOUR
The present invention relates to a method for producing a flavour composition comprising providing a slurry of yeast cell walls and contacting the slurry of yeast cell walls with a glucanase and with an endoprotease, followed by separating a liquid fraction by solid/liquid separation to provide the liquid flavour composition.
Yeast cell wall derived flavour
The present invention relates to a method for producing a flavour composition comprising providing a slurry of yeast cell walls and contacting the slurry of yeast cell walls with a glucanase and with an endoprotease, followed by separating a liquid fraction by solid/liquid separation to provide the liquid flavour composition.
Yeast cell wall derived flavour
The present invention relates to a method for producing a flavour composition comprising providing a slurry of yeast cell walls and contacting the slurry of yeast cell walls with a glucanase and with an endoprotease, followed by separating a liquid fraction by solid/liquid separation to provide the liquid flavour composition.
COMPOSITION, FOOD SUPPLEMENT, COMPOSITION ACTING AS A FOOD SUPPLEMENT FOR CHILDREN, AND PRODUCTION METHOD
A composition, containing a pepper component, a curcumin-cyclodextrin mixture and a mixture of fruits, vegetables and spices.
COMPOSITION, FOOD SUPPLEMENT, COMPOSITION ACTING AS A FOOD SUPPLEMENT FOR CHILDREN, AND PRODUCTION METHOD
A composition, containing a pepper component, a curcumin-cyclodextrin mixture and a mixture of fruits, vegetables and spices.
METHOD FOR STIMULATING GROWTH OF BACTERIA IN THE GUT MICROBIOTA OF A MAMMAL
A method is for stimulating the growth of bacteria of the Bacteroidetes phylum in the gut microbiota of a mammal. The method includes administering a yeast product as a prebiotic agent to the mammal. The yeast product comprises the walls of yeast cells, such as those of the genera Saccharomyces, Pichia, Candida, Kluyveromyces, Yarrowia and/or Wickehomomyces, or a fraction thereof.
NOVEL KAZACHSTANIA TURICENSIS CAU Y1706 AND COMPOSITION USING SAME
The present invention relates to a novel Kazachstania turicensis CAU Y1706 and a composition using same, and more specifically, to a Kazachstania turicensis CAU Y1706 (Accession No.: KCTC13794BP) strain, and a pharmaceutical composition, a food composition, a cosmetic composition, and a probiotic composition for preventing or treating inflammatory diseases, comprising the strain or a culture thereof as an active ingredient.
Composition of heat-killed yeast and taurine or a phytomedicine for the treatment of chronic inflammation
An anti-inflammatory composition of Candida albicans which comprises heat-killed Candida albicans in combination with a neuroprotective supplement. The composition provides a method of stimulating a host immune response capable of reducing a total Candida albicans yeast load below the threshold necessary for the host to keep the Candida albicans yeast and related yeast species in a commensal, non-invasive state. This effect inhibits or prevents chronic inflammation related to invasive Candida genus and allows the composition to be useful for the prevention, prophylaxis, and/or treatment of chronic inflammatory conditions, as well as diseases and disorders of the central nervous system resulting from high L-glutamate levels due to Candida albicans in the gastrointestinal system.
METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING CENTRAL NERVOUS SYSTEM DISORDERS AND OTHER CONDITIONS CAUSED BY GUT MICROBIAL DYSBIOSIS
The technology described herein is directed to compositions and methods for treating CNS diseases or disorders associated with microbiome dysbiosis. In one aspect, described herein are compositions and methods for treating CNS diseases or disorders associated with a microbiome deficient in queuine biosynthesis. In another aspect, described herein are compositions and methods for treating CNS diseases or disorders associated with a microbiome deficient in endozepine biosynthesis. In another aspect, described herein are compositions and methods for treating CNS diseases or disorders associated with a microbiome deficient in heavy metal sequestration.
METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING CENTRAL NERVOUS SYSTEM DISORDERS AND OTHER CONDITIONS CAUSED BY GUT MICROBIAL DYSBIOSIS
The technology described herein is directed to compositions and methods for treating CNS diseases or disorders associated with microbiome dysbiosis. In one aspect, described herein are compositions and methods for treating CNS diseases or disorders associated with a microbiome deficient in queuine biosynthesis. In another aspect, described herein are compositions and methods for treating CNS diseases or disorders associated with a microbiome deficient in endozepine biosynthesis. In another aspect, described herein are compositions and methods for treating CNS diseases or disorders associated with a microbiome deficient in heavy metal sequestration.